Raloxifene (Evista), a new "designer estrogen"

    Lots of women are asking about raloxifene (Evista), a new "designer estrogen." It's been on the Today show, CNN, etc.

    Lilly is testing raloxifene to prevent osteoporosis in postmenopausal women...as an alternative to using estrogen.

    Raloxifene is actually similar to tamoxifen (Nolvadex).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote